[HTML][HTML] Active surveillance as a management strategy for papillary thyroid microcarcinoma
H Zhang, X Zheng, J Liu, M Gao… - Cancer Biology & …, 2020 - ncbi.nlm.nih.gov
Active surveillance (AS) can be considered as a treatment strategy for low risk papillary
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
Active surveillance as a management strategy for papillary thyroid microcarcinoma.
H Zhang, X Zheng, J Liu, M Gao… - Cancer Biology & …, 2020 - search.ebscohost.com
Active surveillance (AS) can be considered as a treatment strategy for low risk papillary
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
[PDF][PDF] Active surveillance as a management strategy for papillary thyroid microcarcinoma
H Zhang, X Zheng, J Liu, M Gao, B Qian - 2020 - pdfs.semanticscholar.org
Active surveillance (AS) can be considered as a treatment strategy for low risk papillary
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
[HTML][HTML] Active surveillance as a management strategy for papillary thyroid microcarcinoma
H Zhang, X Zheng, J Liu, M Gao… - Cancer Biology & …, 2020 - cancerbiomed.org
Active surveillance (AS) can be considered as a treatment strategy for low risk papillary
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
Active surveillance as a management strategy for papillary thyroid microcarcinoma
H Zhang, X Zheng, J Liu, M Gao… - Cancer biology & …, 2020 - pubmed.ncbi.nlm.nih.gov
Active surveillance (AS) can be considered as a treatment strategy for low risk papillary
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
Active surveillance as a management strategy for papillary thyroid microcarcinoma
H Zhang - Cancer Biology & Medicine, 2020 - search.proquest.com
Active surveillance (AS) can be considered as a treatment strategy for low risk papillary
thyroid microcarcinoma (PTMC), withthe absence of clinically apparent lymph nodes …
thyroid microcarcinoma (PTMC), withthe absence of clinically apparent lymph nodes …
Active surveillance as a management strategy for papillary thyroid microcarcinoma.
H Zhang, X Zheng, J Liu, M Gao… - Cancer Biology & Medicine, 2020 - europepmc.org
Active surveillance (AS) can be considered as a treatment strategy for low risk papillary
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
Active surveillance as a management strategy for papillary thyroid microcarcinoma
H Zhang, X Zheng, J Liu, M Gao… - Cancer Biology & …, 2020 - search.proquest.com
Active surveillance (AS) can be considered as a treatment strategy for low risk papillary
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
[PDF][PDF] Active surveillance as a management strategy for papillary thyroid microcarcinoma
H Zhang, X Zheng, J Liu, M Gao, B Qian - 2020 - cancerbiomed.org
Active surveillance (AS) can be considered as a treatment strategy for low risk papillary
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …
thyroid microcarcinoma (PTMC), with the absence of clinically apparent lymph nodes …